Sakanaka, K., Sasaki, K., Tsushima, T., Machida, R., Hamai, Y., Watanabe, A., Kawabata, K., Matsuda, S., Kato, K., Fukuda, H., Takeuchi, H. (2026). Randomized controlled phase II trial comparing nivolumab, ipilimumab plus radiotherapy versus nivolumab plus ipilimumab for metastatic or recurrent esophageal cancer: Japan Clinical Oncology Group study JCOG2311 (ART NOUVEAU).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps461